154 related articles for article (PubMed ID: 28255192)
1. Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer.
Stępień T; Brożyna M; Kuzdak K; Motylewska E; Komorowski J; Stępień H; Ławnicka H
Dis Markers; 2017; 2017():4962137. PubMed ID: 28255192
[No Abstract] [Full Text] [Related]
2. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum concentrations of IGF-1 and IGF-1R in patients with thyroid cancers.
Lawnicka H; Motylewska E; Borkowska M; Kuzdak K; Siejka A; Swietoslawski J; Stepien H; Stepien T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):77-83. PubMed ID: 31132076
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of serum DKK-1 predicts poor prognosis in patients with papillary thyroid cancer.
Zhao YP; Wang W; Wang XH; Xu Y; Wang Y; Dong ZF; Zhang JJ
Genet Mol Res; 2015 Dec; 14(4):18886-94. PubMed ID: 26782539
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
Meng XY; Zhang Q; Li Q; Lin S; Li J
J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers?
Razavi SA; Modarressi MH; Yaghmaei P; Tavangar SM; Hedayati M
Endocrine; 2017 Sep; 57(3):428-435. PubMed ID: 28755140
[TBL] [Abstract][Full Text] [Related]
7. Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?
Ria R; Prete F; Melaccio A; Di Meo G; Saltarella I; Solimando AG; Gurrado A; Ferraro V; Pasculli A; Sgaramella LI; Racanelli V; Vacca A; Testini M
Surgery; 2021 Jan; 169(1):27-33. PubMed ID: 32482341
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of clathrin promotes thyroid cell growth and contributes to multinodular goiter pathogenesis.
Lau ST; Zhou T; Liu JA; Fung EY; Che CM; Lang BH; Ngan ES
Biochim Biophys Acta; 2015 Aug; 1852(8):1676-86. PubMed ID: 25981745
[TBL] [Abstract][Full Text] [Related]
9. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
10. Nuclear receptor expression in human differentiated thyroid tumors.
Mond M; Alexiadis M; Eriksson N; Davis MJ; Muscat GE; Fuller PJ; Gilfillan C
Thyroid; 2014 Jun; 24(6):1000-11. PubMed ID: 24559275
[TBL] [Abstract][Full Text] [Related]
11. Expression of the NOB1 gene and its clinical significance in papillary thyroid carcinoma.
Lin S; Meng W; Zhang W; Liu J; Wang P; Xue S; Chen G
J Int Med Res; 2013 Jun; 41(3):568-72. PubMed ID: 23685895
[TBL] [Abstract][Full Text] [Related]
12. [Thyroid masses: an analysis of 131 cases].
Cağli S; Yüce I; Bayram A; Güney E
Kulak Burun Bogaz Ihtis Derg; 2008; 18(5):289-93. PubMed ID: 19155674
[TBL] [Abstract][Full Text] [Related]
13. Incidental thyroid cancer in toxic and nontoxic goiter: Is TSH associated with malignanCy rate? Results of a meta-analysis.
Negro R; Valcavi R; Toulis KA
Endocr Pract; 2013; 19(2):212-8. PubMed ID: 23186976
[TBL] [Abstract][Full Text] [Related]
14. Trends in white blood cell and platelet indices in a comparison of patients with papillary thyroid carcinoma and multinodular goiter do not permit differentiation between the conditions.
Machairas N; Kostakis ID; Prodromidou A; Stamopoulos P; Feretis T; Garoufalia Z; Damaskos C; Tsourouflis G; Kouraklis G
Endocr Res; 2017 Nov; 42(4):311-317. PubMed ID: 28506088
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.
Yu H; Huang X; Liu X; Jin H; Zhang G; Zhang Q; Yu J
Endocrine; 2013 Aug; 44(1):172-81. PubMed ID: 23264145
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin and obestatin in thyroid gland - immunohistochemical expression in nodular goiter, papillary and medullary cancer.
Gurgul E; Kasprzak A; Blaszczyk A; Biczysko M; Surdyk-Zasada J; Seraszek-Jaros A; Ruchala M
Folia Histochem Cytobiol; 2015; 53(1):19-25. PubMed ID: 25765090
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of expression of LGALS3BP gene in thyroid tissues and peripheral blood lymphocytes in patients with papillary thyroid cancer].
Kaliszewski K; Łukieńczuk T; Dobosz T; Rzeszutko M; Sadakierska-Chudy A
Endokrynol Pol; 2006; 57 Suppl A():38-44. PubMed ID: 17091455
[TBL] [Abstract][Full Text] [Related]
18. Role of Ki-67 as a proliferative marker in lesions of thyroid.
Pujani M; Arora B; Pujani M; Singh SK; Tejwani N
Indian J Cancer; 2010; 47(3):304-7. PubMed ID: 20587907
[TBL] [Abstract][Full Text] [Related]
19. Alteration in the serum concentrations of FGF19, FGFR4 and βKlotho in patients with thyroid cancer.
Motylewska E; Stępień T; Borkowska M; Kuzdak K; Siejka A; Komorowski J; Stępień H; Ławnicka H
Cytokine; 2018 May; 105():32-36. PubMed ID: 29438906
[TBL] [Abstract][Full Text] [Related]
20. Hyalinizing trabecular tumour of the thyroid-differential expression of distinct miRNAs compared with papillary thyroid carcinoma.
Sheu SY; Vogel E; Worm K; Grabellus F; Schwertheim S; Schmid KW
Histopathology; 2010 Apr; 56(5):632-40. PubMed ID: 20459574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
